biotech funding

Alphabet's Isomorphic Labs raised $2.1 billion in funding to advance AI drug discovery toward clinical trials. This massive investment signals growing confidence in AI's ability to accelerate pharmaceutical development, potentially reducing the traditional 10-15 year drug development timeline.